The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20120073: The Edward W. Scripps Trust; The McGraw-Hill Companies, Inc.
20120066: Sonoco Products Company; Metalmark Capital Partners, L.P.
20120064: Vention Medical, Inc.; Christine Bieber Orris
20120062: Steiner Leisure Limited; Ideal Image Development, Inc.
20120055: G4S plc; FS Invest S.a.r.l.
20120054: Tunstall Healthcare Group Limited; American Medical Alert Corp.
20120053: TTT Holdings, Inc.; John Boyle
20120058: Lafarge S.A.; Martin Marietta Materials, Inc.
20120057: Martin Marietta Materials, Inc.; Lafarge S.A.
20120047: Boise Inc.; Pregis Holding I Corporation
20120038: Rock-Tenn Company; Donald T. Kindt
20120030: Tri-State Generation and Transmission Association, Inc.; Starwood Energy Infrastructure
20120019: Getinge AB; Atrium Medical Corporation
20120017: Trian Partners Strategic Investment Fund, L.P.; Family Dollar Stores, Inc.
20120003: Vista Equity Partners Fund IV, L.P.; The Sage Group plc
20120050: J.C. Penney Company, Inc.; Liz Claiborne, Inc.
DaVita Inc.
The Commission required dialysis services company DaVita, Inc. to sell 29 outpatient dialysis clinics around the United States, under a settlement that resolves FTC charges that DaVita’s proposed $689 million acquisition of rival CDSI I Holding Company, Inc., also known as DSI, would be anticompetitive. The settlement preserves competition in 22 geographic markets where the FTC alleges that consumers would be harmed by DaVita’s acquisition of DSI. The settlement requires DaVita to sell the clinics to Dialysis Newco, Inc., a corporation formed by venture capital firms Frazier Healthcare and New Enterprise Associates.